Literature DB >> 34514881

Acquisition of Developmental Milestones in Hypomyelination With Atrophy of the Basal Ganglia and Cerebellum and Other TUBB4A-Related Leukoencephalopathy.

Francesco Gavazzi1,2, Brittany A Charsar3, Catherine Williams1, Justine Shults4,5, Cesar A Alves6, Laura Adang1,7, Adeline Vanderver1,7.   

Abstract

Mutations in TUBB4A are associated with a spectrum of neurologic disorders categorized as TUBB4A-related leukoencephalopathy. Affected children can present with global developmental delay or normal early development, followed by a variable loss of skills over time. Further research is needed to characterize the factors associated with the divergent developmental trajectories in this rare monogenic disorder because this phenotypic spectrum is not fully explained by genotype alone.To characterize early psychomotor features, developmental milestones and age of disease onset were collected from medical records (n=54 individuals). Three subcohorts were identified: individuals with the common p.Asp249Asn variant vs all other genotypes with either early (<12 months of age) or late onset of presentation. Individuals with the p.Asp249Asn variant or those with non-p.Asp249Asn genotypes with later disease onset attained key milestones, including head control, sitting, and independent walking. Subjects with early-onset, non-p.Asp249Asn-associated disease were less likely to achieve developmental milestones. Next, we defined the developmental severity as the percentage of milestones attained by age 2 years. The mild form was defined as attaining at least 75% of key developmental milestones. Among cohort categorized as mild, individuals with p.Asp249Asn variant were more likely to lose acquired abilities when compared with non-p.Asp249Asn individuals.Our results suggest multiple influences on developmental trajectory, including a strong contribution from genotype and age of onset. Further studies are needed to identify additional factors that influence overall outcomes to better counsel families and to design clinical trials with appropriate clinical endpoints.

Entities:  

Keywords:  developmental delay; genetics; leukodystrophy; neurodevelopment; pediatric

Mesh:

Substances:

Year:  2021        PMID: 34514881      PMCID: PMC8505576          DOI: 10.1177/08830738211000977

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   2.363


  18 in total

1.  Developmental Outcomes of Aicardi Goutières Syndrome.

Authors:  Laura Adang; Francesco Gavazzi; Micaela De Simone; Elisa Fazzi; Jessica Galli; Jamie Koh; Julia Kramer-Golinkoff; Valentina De Giorgis; Simona Orcesi; Kyle Peer; Nicole Ulrick; Sarah Woidill; Justine Shults; Adeline Vanderver
Journal:  J Child Neurol       Date:  2019-09-27       Impact factor: 1.987

2.  De Novo mutations in the β-tubulin gene TUBB4: from DYT4 to leukoencephalopathy with hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC syndrome).

Authors:  Athanasia Alexoudi; Susanne A Schneider
Journal:  Mov Disord       Date:  2013-09-06       Impact factor: 10.338

3.  Tumoral and tissue-specific expression of the major human beta-tubulin isotypes.

Authors:  Luis J Leandro-García; Susanna Leskelä; Iñigo Landa; Cristina Montero-Conde; Elena López-Jiménez; Rocío Letón; Alberto Cascón; Mercedes Robledo; Cristina Rodríguez-Antona
Journal:  Cytoskeleton (Hoboken)       Date:  2010-04

4.  Expansion of the spectrum of TUBB4A-related disorders: a new phenotype associated with a novel mutation in the TUBB4A gene.

Authors:  Lubov Blumkin; Ayelet Halevy; Dominique Ben-Ami-Raichman; Dvir Dahari; Ami Haviv; Cohen Sarit; Dorit Lev; Marjo S van der Knaap; Tally Lerman-Sagie; Esther Leshinsky-Silver
Journal:  Neurogenetics       Date:  2014-02-14       Impact factor: 2.660

5.  Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene.

Authors:  Katja Lohmann; Robert A Wilcox; Susen Winkler; Alfredo Ramirez; Aleksandar Rakovic; Jin-Sung Park; Björn Arns; Thora Lohnau; Justus Groen; Meike Kasten; Norbert Brüggemann; Johann Hagenah; Alexander Schmidt; Frank J Kaiser; Kishore R Kumar; Katja Zschiedrich; Daniel Alvarez-Fischer; Eckart Altenmüller; Andreas Ferbert; Anthony E Lang; Alexander Münchau; Vladimir Kostic; Kristina Simonyan; Marc Agzarian; Laurie J Ozelius; Antonius P M Langeveld; Carolyn M Sue; Marina A J Tijssen; Christine Klein
Journal:  Ann Neurol       Date:  2013-04-17       Impact factor: 10.422

6.  TUBB4A de novo mutations cause isolated hypomyelination.

Authors:  Amy Pizzino; Tyler Mark Pierson; Yiran Guo; Guy Helman; Sebastian Fortini; Kether Guerrero; Sulagna Saitta; Jennifer Louise Patrick Murphy; Quasar Padiath; Yi Xie; Hakon Hakonarson; Xun Xu; Tara Funari; Michelle Fox; Ryan J Taft; Marjo S van der Knaap; Geneviève Bernard; Raphael Schiffmann; Cas Simons; Adeline Vanderver
Journal:  Neurology       Date:  2014-08-01       Impact factor: 9.910

7.  TUBB4A mutations result in specific neuronal and oligodendrocytic defects that closely match clinically distinct phenotypes.

Authors:  Julian Curiel; Guillermo Rodríguez Bey; Asako Takanohashi; Marianna Bugiani; Xiaoqin Fu; Nicole I Wolf; Bruce Nmezi; Raphael Schiffmann; Mona Bugaighis; Tyler Pierson; Guy Helman; Cas Simons; Marjo S van der Knaap; Judy Liu; Quasar Padiath; Adeline Vanderver
Journal:  Hum Mol Genet       Date:  2017-11-15       Impact factor: 6.150

8.  H-ABC syndrome and DYT4: Variable expressivity or pleiotropy of TUBB4 mutations?

Authors:  Roberto Erro; Joshua Hersheson; Christos Ganos; Niccoló E Mencacci; Maria Stamelou; Amit Batla; Stefanie Catherine Thust; Jose M Bras; Rita J Guerreiro; John Hardy; Niall P Quinn; Henry Houlden; Kailash P Bhatia
Journal:  Mov Disord       Date:  2014-12-27       Impact factor: 10.338

Review 9.  Microtubules and neurodevelopmental disease: the movers and the makers.

Authors:  Martin Breuss; David A Keays
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

10.  Mutations in the autoregulatory domain of β-tubulin 4a cause hereditary dystonia.

Authors:  Joshua Hersheson; Niccolo E Mencacci; Mary Davis; Nicola MacDonald; Daniah Trabzuni; Mina Ryten; Alan Pittman; Reema Paudel; Eleanna Kara; Katherine Fawcett; Vincent Plagnol; Kailash P Bhatia; Alan J Medlar; Horia C Stanescu; John Hardy; Robert Kleta; Nicholas W Wood; Henry Houlden
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

View more
  1 in total

1.  Reliability of the Telemedicine Application of the Gross Motor Function Measure-88 in Patients With Leukodystrophy.

Authors:  Francesco Gavazzi; Laura Adang; Amy Waldman; Amanda K Jan; Geraldine Liu; Scott A Lorch; Sara B DeMauro; Justine Shults; Samuel R Pierce; Elizabeth Ballance; Tracy Kornafel; Ann Harrington; Allan M Glanzman; Adeline Vanderver
Journal:  Pediatr Neurol       Date:  2021-09-24       Impact factor: 4.210

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.